Showing results (721-730 of 2,410) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|March 24, 2025
Hepatocellular carcinoma: what are the differential costs compared to the general population?Josep Darbà, Meritxell AscanioJournal of Medical Economics|March 24, 2025
Patient and physician preferences for treatment of hepatitis C virus infection in Japan: a discrete choice experimentDaisuke Nakamoto, Yi Piao, Hajime Mizutani, et al.Journal of Medical Economics|May 7, 2013
Budget impact of rosuvastatin initiation in high-risk hyperlipidemic patients from a US managed care perspectiveC Montouchet, L Ruff, S BaluJournal of Medical Economics|May 8, 2013
Understanding the effects on HR-QoL of treatment for overactive bladder: a detailed analysis of EQ-5D clinical trial data for mirabegronM Pavesi, N Devlin, Z Hakimi, et al.Journal of Medical Economics|May 8, 2013
Cost and utilization of healthcare services for hip and knee replacementChris M Kozma, Terra Slaton, Andy Paris, et al.Journal of Medical Economics|February 22, 2013
The burden of blood transfusion: a utilization and economic analysis--a pilot study in patients with chemotherapy-induced anemia (CIA)John F Reitan, Fred J Kudrik, Kayleen Fox, et al.Journal of Medical Economics|February 22, 2013
Longitudinal analysis of healthcare costs: a case study of patients with major depressive disorder treated with duloxetineZhanglin Cui, Douglas E Faries, Wei Shen, et al.Journal of Medical Economics|February 22, 2013
Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health planCindy Garris, Priti Jhingran, Damon Bass, et al.Journal of Medical Economics|February 22, 2013
Cost effectiveness of liposomal doxorubicin vs. paclitaxel for the treatment of advanced AIDS-Kaposi's sarcomaKarina Raimundo, Joseph Biskupiak, Michael Goodman, et al.Journal of Medical Economics|February 23, 2013
Medical resource use and costs associated with chylomicronemiaDaniel Gaudet, James Signorovitch, Elyse Swallow, et al.Pageof 241